105241-80-3

Basic information

• Product Name: 4-(2-chlorophenyl)-9-cyclopropyl-2-(9-morpholin-4-yl-9-oxononyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
• Synonyms: Morpholine, 4-(9-(4-(2-chlorophenyl)-9-cyclopropyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-2-yl)-1-oxononyl)-
• CAS NO: 105241-80-3
• Molecular Formula: C₃₀H₃₆ClN₅O₂S
• Molecular Weight: 566.1571
• Mol File: 105241-80-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 778.6°C at 760 mmHg
• Flash Point: 424.7°C
• Density: 1.39g/cm³
• Vapor Pressure: 3.51E-24mmHg at 25°C
• Refractive Index: 1.699
• CAS DataBase Reference: 4-(2-chlorophenyl)-9-cyclopropyl-2-(9-morpholin-4-yl-9-oxononyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-chlorophenyl)-9-cyclopropyl-2-(9-morpholin-4-yl-9-oxononyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine(105241-80-3)
• EPA Substance Registry System: 4-(2-chlorophenyl)-9-cyclopropyl-2-(9-morpholin-4-yl-9-oxononyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine(105241-80-3)

Safety Data

• Hazardous Substances Data: 105241-80-3(Hazardous Substances Data)

Relevant articles and documents

Thieno-traizolo-1,4-diazepino-2-carboxylic acid amides

The invention relates to new thieno-traizolo-1,4-diazepino-2-carboxylic acid amides of formula I STR1 wherein R 1 represents hydrogen, a C 1 -C 4 straight-chained or branched alkyl which can optionally be substituted by halogen, preferably Cl or Br, or by hydroxy, cyclopropyl, C 1 -C 3 alkoxy, preferably methoxy, or halogen, preferably chlorine or bromine;R 2 and R 3, each independently, represent hydrogen, a C 1 -C 4 straight-chained or branched alkyl, C 1 -C 4 hydroxyalkyl or the two groups R 2 and R 3 together with the nitrogen atom represent a 5-, 6- or 7-membered ring which optionally contains a nitrogen, oxygen or sulfur atom as a further heteroatom, the second nitrogen atom optionally being substituted by a C 1 -C 4 alkyl, preferably a methyl group;R 4 represents alpha-pyridyl or a phenyl in which the phenyl ring can be substituted preferably in the 2-position, by methyl, halogen, preferably chlorine or bromine, nitro or trifluoromethyl;n represents one of the numbers 0, 1, 2, 3, 4, 5, 6, 7 or 8; and novel intermediates therefor.The compounds of formula I are useful in the treatment of pathological conditions and diseases in which platelet activating factor is implicated.